Interplay between antibacterial effectors: a macrophage antimicrobial peptide impairs intracellular Salmonella replication.

Antimicrobial peptides have established an important role in the defense against extracellular infections, but the expression of cationic peptides within macrophages as an antibacterial effector mechanism against intracellular pathogens has not been demonstrated. Macrophage expression of the murine cathelicidin-related antimicrobial peptide (CRAMP) was increased after infection by the intracellular pathogen Salmonella typhimurium, and this increase required reactive oxygen intermediates. By using CRAMP-deficient mice or synthetic CRAMP peptide, we found that CRAMP impaired Salmonella cell division in vivo and in vitro, resulting in long filamentous bacteria. This impaired bacterial cell division also depended on intracellular elastase-like serine protease activity, which can proteolytically activate cathelicidins. Macrophage serine protease activity induced filamentation and enhanced the activity of CRAMP in vitro. A peptide-sensitive Salmonella mutant showed enhanced survival within macrophages derived from CRAMP-deficient mice, indicating that Salmonella can sense and respond to cationic peptides in the intracellular environment. Although cationic peptides have been hypothesized to have activity against pathogens within macrophages, this work provides experimental evidence that the antimicrobial arsenal of macrophages includes cathelicidins. These results show that intracellular reactive oxygen intermediates and proteases regulate macrophage CRAMP expression and activity to impair the replication of an intracellular bacterial pathogen, and they highlight the cooperativity between macrophage antibacterial effectors.

[1]  Samuel I. Miller,et al.  Regulation of Salmonella typhimurium virulence gene expression by cationic antimicrobial peptides , 2003, Molecular microbiology.

[2]  F. Fang,et al.  Inhibition of bacterial DNA replication by zinc mobilization during nitrosative stress , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[3]  Carrie M. Rosenberger,et al.  Phagocyte sabotage: disruption of macrophage signalling by bacterial pathogens , 2003, Nature Reviews Molecular Cell Biology.

[4]  N. Salzman,et al.  Protection against enteric salmonellosis in transgenic mice expressing a human intestinal defensin , 2003, Nature.

[5]  Takaaki Ohtake,et al.  Biology and clinical relevance of naturally occurring antimicrobial peptides. , 2002, The Journal of allergy and clinical immunology.

[6]  Göran Carlsson,et al.  Deficiency of antibacterial peptides in patients with morbus Kostmann: an observation study , 2002, The Lancet.

[7]  Tomas Ganz,et al.  Endogenous antimicrobial peptides and skin infections in atopic dermatitis. , 2002, The New England journal of medicine.

[8]  R. Gallo,et al.  Cathelicidins, essential gene-encoded mammalian antibiotics , 2002, Journal of Molecular Medicine.

[9]  B. Finlay,et al.  Macrophages Inhibit Salmonella Typhimurium Replication through MEK/ERK Kinase and Phagocyte NADPH Oxidase Activities* , 2002, The Journal of Biological Chemistry.

[10]  M. Hensel,et al.  Salmonella Pathogenicity Island 2 Mediates Protection of Intracellular Salmonella from Reactive Nitrogen Intermediates , 2002, The Journal of experimental medicine.

[11]  S. Shapiro,et al.  Neutrophil elastase targets virulence factors of enterobacteria , 2002, Nature.

[12]  Giorgio Gabella,et al.  Killing activity of neutrophils is mediated through activation of proteases by K+ flux , 2002, Nature.

[13]  Mario Del Rosso,et al.  Non-Enzymatic Activities of Proteases: From Scepticism to Reality , 2002, Biological chemistry.

[14]  Takaaki Ohtake,et al.  Innate antimicrobial peptide protects the skin from invasive bacterial infection , 2001, Nature.

[15]  Jonathan D. Cohen,et al.  Intracellular replication of Salmonella typhimurium strains in specific subsets of splenic macrophages in vivo , 2001, Cellular microbiology.

[16]  K. Kisich,et al.  Antimycobacterial Agent Based on mRNA Encoding Human β-Defensin 2 Enables Primary Macrophages To Restrict Growth ofMycobacterium tuberculosis , 2001, Infection and Immunity.

[17]  T. Ganz,et al.  Inhibition of neutrophil elastase prevents cathelicidin activation and impairs clearance of bacteria from wounds. , 2001, Blood.

[18]  S. Shapiro,et al.  Degradation of outer membrane protein A in Escherichia coli killing by neutrophil elastase. , 2000, Science.

[19]  R. Hancock,et al.  The role of antimicrobial peptides in animal defenses. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[20]  F. Fang,et al.  Antimicrobial Actions of the Nadph Phagocyte Oxidase and Inducible Nitric Oxide Synthase in Experimental Salmonellosis. I. Effects on Microbial Killing by Activated Peritoneal Macrophages in Vitro , 2000, The Journal of experimental medicine.

[21]  F. Fang,et al.  Salmonella pathogenicity island 2-dependent evasion of the phagocyte NADPH oxidase. , 2000, Science.

[22]  James M. Wilson,et al.  Augmentation of Innate Host Defense by Expression of a Cathelicidin Antimicrobial Peptide , 1999, Infection and Immunity.

[23]  Ronald McCarthy,et al.  Mice lacking neutrophil elastase reveal impaired host defense against gram negative bacterial sepsis , 1998, Nature Medicine.

[24]  C. Subbalakshmi,et al.  Mechanism of antimicrobial action of indolicidin. , 1998, FEMS microbiology letters.

[25]  B. Finlay,et al.  Murine Salmonellosis Studied by Confocal Microscopy: Salmonella typhimurium Resides Intracellularly Inside Macrophages and Exerts a Cytotoxic Effect on Phagocytes In Vivo , 1997, The Journal of experimental medicine.

[26]  S. Welkos,et al.  Bacterial filamentation of Yersinia pestis by beta-lactam antibiotics in experimentally infected mice. , 1997, Archives of pathology & laboratory medicine.

[27]  C. Kozak,et al.  Identification of CRAMP, a Cathelin-related Antimicrobial Peptide Expressed in the Embryonic and Adult Mouse* , 1997, The Journal of Biological Chemistry.

[28]  S. Miller,et al.  Regulation of lipid A modifications by Salmonella typhimurium virulence genes phoP-phoQ. , 1997, Science.

[29]  T. Ganz,et al.  Inhibition of intracellular Histoplasma capsulatum replication by murine macrophages that produce human defensin , 1994, Infection and immunity.

[30]  E. Groisman,et al.  Resistance to host antimicrobial peptides is necessary for Salmonella virulence. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[31]  S. Miller,et al.  A two-component regulatory system (phoP phoQ) controls Salmonella typhimurium virulence. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[32]  E. Groisman,et al.  A Salmonella locus that controls resistance to microbicidal proteins from phagocytic cells. , 1989, Science.

[33]  F. Heffron,et al.  Intracellular survival of wild-type Salmonella typhimurium and macrophage-sensitive mutants in diverse populations of macrophages , 1989, Infection and immunity.

[34]  R. Crystal,et al.  Myelomonocytic cell lineage expression of the neutrophil elastase gene. , 1988, The Journal of biological chemistry.

[35]  S. Linn,et al.  Mutagenesis and stress responses induced in Escherichia coli by hydrogen peroxide , 1987, Journal of bacteriology.

[36]  M. Selsted,et al.  Primary structures of MCP-1 and MCP-2, natural peptide antibiotics of rabbit lung macrophages. , 1983, The Journal of biological chemistry.

[37]  M. Selsted,et al.  Antibacterial activity of microbicidal cationic proteins 1 and 2, natural peptide antibiotics of rabbit lung macrophages , 1983, Infection and immunity.

[38]  F. R. Cox,et al.  Elastase of U-937 monocytelike cells. Comparisons with elastases derived from human monocytes and neutrophils and murine macrophagelike cells. , 1982, The Journal of clinical investigation.